Discovery of 6-benzyloxyquinolines as c-Met selective kinase inhibitors
Nishii, H., Chiba, T., Morikami, K., Fukami, T.A., Sakamoto, H., Ko, K., Koyano, H.(2010) Bioorg Med Chem Lett 20: 1405-1409
- PubMed: 20093027 
- DOI: https://doi.org/10.1016/j.bmcl.2009.12.109
- Primary Citation of Related Structures:  
3A4P - PubMed Abstract: 
A novel quinoline derivative that selectively inhibits c-Met kinase was identified. The molecular design is based on a result of the analysis of a PF-2341066 (1)/c-Met cocrystal structure (PDB code: 2wgj). The kinase selectivity of the derivatives is discussed from the view point of the sequence homology of the kinases, the key interactions found in X-ray cocrystal structures, and the structure-activity relationship (SAR) obtained in this work.
Organizational Affiliation: 
Department of Chemistry Research 2, Chugai Pharmaceutical Co, Ltd, 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.